Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

PSAT1 is key for hair growth and stem cell function in cashmere goats.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

Oral testosterone therapy raises heart risk more than other methods.

Higher uric acid levels are linked to fewer urinary symptoms in healthy Korean men.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Both lasers are equally effective and safe for treating freckles.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.